<SEC-DOCUMENT>0001701478-26-000029.txt : 20260513
<SEC-HEADER>0001701478-26-000029.hdr.sgml : 20260513
<ACCEPTANCE-DATETIME>20260512200952
ACCESSION NUMBER:		0001701478-26-000029
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260513
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260513
DATE AS OF CHANGE:		20260512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Azitra, Inc.
		CENTRAL INDEX KEY:			0001701478
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				464478536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41705
		FILM NUMBER:		26970472

	BUSINESS ADDRESS:	
		STREET 1:		21 BUSINESS PARK DRIVE, SUITE 6
		CITY:			BRANFORD
		STATE:			CT
		ZIP:			06405
		BUSINESS PHONE:		(203) 489-0183

	MAIL ADDRESS:	
		STREET 1:		21 BUSINESS PARK DRIVE, SUITE 6
		CITY:			BRANFORD
		STATE:			CT
		ZIP:			06405

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Azitra Inc
		DATE OF NAME CHANGE:	20170320
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aztr-20260513.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d259a-22e3-7c8b-971e-5774f3923c7f,g:56b54348-e223-4b5f-97fa-e119bcd9767f,d:01ff4e28a1cf4159bb12b214304b3808-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>aztr-20260513</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-23">0001701478</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="aztr-20260513.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701478</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-02-27</xbrli:startDate><xbrli:endDate>2026-02-27</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i01ff4e28a1cf4159bb12b214304b3808_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">___________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">___________________________________</span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (date of earliest event reported):  </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">May&#160;13, 2026</ix:nonNumeric></span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">___________________________________</span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">AZITRA, INC.</ix:nonNumeric></span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">___________________________________</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.92pt;padding-right:0.92pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></div><div style="padding-left:0.92pt;padding-right:0.92pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(State or other jurisdiction of </span></div><div style="padding-left:0.92pt;padding-right:0.92pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-41705</ix:nonNumeric></span></div><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">46-4478536</ix:nonNumeric></span></div><div style="margin-bottom:0.08pt;padding-left:0.95pt;padding-right:0.95pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%">(I.R.S. Employer Identification Number)</span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.92pt;padding-right:3.92pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">21 Business Park Drive</ix:nonNumeric></span></div><div style="margin-bottom:0.08pt;padding-left:3.92pt;padding-right:3.92pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Branford</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">CT</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">06405</ix:nonNumeric></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.37pt;padding-right:4.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices and zip code)</span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">(203)</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">646-6446</ix:nonNumeric></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.37pt;padding-right:4.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Registrant's telephone number, including area code)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%">(Former name or former address, if changed since last report.)</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">___________________________________</span></div><div style="margin-top:10.8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.852%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.9pt;padding-right:1.9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.9pt;padding-right:1.9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.9pt;padding-right:1.9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.9pt;padding-right:1.9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.823%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.4pt;padding-right:4.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Title of each class</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Trading Symbol</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $0.0001</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">AZTR</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">NYSE American</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:5.4pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).</span></div><div style="padding-left:360pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Emerging growth company&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-20">&#9746;</ix:nonNumeric></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="margin-top:5.4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:0.08pt;text-align:justify"><span><br/></span></div><div id="i01ff4e28a1cf4159bb12b214304b3808_7"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:125%">Item 2.02 - Results of Operations and Financial Condition.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On May&#160;13, 2026, Azitra, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results as of and for the quarter ended March 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information in this Item 2.02, including the press release attached as Exhibit 99.1 hereto, is furnished pursuant to Item 2.02 and shall not be deemed &#8220;filed&#8221; for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i01ff4e28a1cf4159bb12b214304b3808_10"></div><div style="-sec-extract:summary;margin-top:5.4pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Item 9.01 - Financial Statements and Exhibits</span></div><div style="margin-top:5.4pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d): The following exhibits are being filed electronically herewith:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.734%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 2.5pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:1.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline">Exhibit No.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 74.5pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:73.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline">Description</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.5pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:1.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">99.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="aztrpressrelease3312026-ex.htm">Press release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="aztrpressrelease3312026-ex.htm">May 12</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="aztrpressrelease3312026-ex.htm">, 2026 regarding the Registrant's financial</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="aztrpressrelease3312026-ex.htm"> results for the fiscal quarter</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="aztrpressrelease3312026-ex.htm"> ended</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="aztrpressrelease3312026-ex.htm"> March 31</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="aztrpressrelease3312026-ex.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="aztrpressrelease3312026-ex.htm">6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="aztrpressrelease3312026-ex.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.9pt;padding-right:1.85pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.9pt;padding-right:1.9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div id="i01ff4e28a1cf4159bb12b214304b3808_13"></div><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%">SIGNATURE</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on May&#160;13, 2026.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.660%"><tr><td style="width:1.0%"/><td style="width:13.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.527%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:1pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%">AZITRA, INC.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1pt;padding-right:1.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></div></td><td colspan="3" style="padding:2px 1pt 2px 2pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:1pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">/s/ Francisco D. Salva</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1pt;padding-right:1.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Name:</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 2pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:1pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Francisco D. Salva</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1pt;padding-right:1.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Title:</span></div></td><td colspan="3" style="padding:2px 1pt 2px 2pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:1pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Chief Executive Officer</span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>aztrpressrelease3312026-ex.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="ia1abca59ecaf42d6b4ce8a96c5d9acf8_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="margin-bottom:9pt;text-align:center"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:200px;margin-bottom:5pt;vertical-align:text-bottom;width:402px"></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">BRANFORD, Conn. &#8211; May&#160;13, 2026 &#8212; Azitra, Inc. (&#8220;Azitra&#8221; or the &#8220;Company&#8221;) (NYSE American&#58; AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the quarter ended March&#160;31, 2026, and provided a business update.</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Q1 2026 and Recent Business Highlights</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Announced the addition of MD Anderson Cancer Center as a clinical site for Phase 1&#47;2 trial of ATR-04 targeting EGFRi-associated skin rash.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Launched innovative protein and peptide programs for the cosmetic and cosmeceutical markets leveraging proprietary filaggrin technologies.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Secured new U.S. patent covering ATR-12, the Company&#8217;s lead product candidate being developed for Netherton syndrome.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Announced poster presentation at American Society of Gene and Cell Therapy Annual Meeting (ASGCT) 2026 highlighting ATR-01 preclinical data and the broader potential of Azitra&#8217;s engineered live biotherapeutic platform.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Priced private placement financing of up to approximately $10.5 million, with up to an additional approximately $20.9 million upon exercise of warrants.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;The first quarter of 2026 marked a period of meaningful execution across our clinical and strategic priorities as we continue to advance Azitra&#8217;s leadership in precision dermatology,&#8221; said Francisco Salva, CEO of Azitra. &#8220;Notably, we significantly grew the clinical footprint for our Phase 1&#47;2 Trial of ATR-04 targeting EGFRi-associated skin rash by adding the world-renowned MD Anderson Cancer Center, which is one of the world&#8217;s premier oncology institutions. We believe the addition of MD Anderson will serve to enhance patient access and support efficient trial execution in EGFR inhibitor-associated rash&#8212;a condition impacting the majority of patients receiving these therapies.&#8221;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Salva continued&#58; &#8220;In parallel, we expanded our strategic footprint with the launch of our cosmeceutical initiative, leveraging our proprietary filaggrin protein and peptide technologies to potentially address large and growing consumer markets. Based on our preliminary research, we are confident that our technologies and expertise can offer an exciting new way to address the appearance of fine lines and wrinkles as well as dry sensitive skin and eczema-like rashes. As such, this program represents a compelling opportunity to extend our platform beyond therapeutics and create additional avenues for value creation.&#8221;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Salva added&#58; &#8220;We are also highlighting our platform this week at ASGCT 2026, where we are presenting ATR-01 preclinical data that underscores the potential of our engineered live biotherapeutics. With this scientific visibility occurring alongside our quarterly update, we believe it reinforces the continued progress and relevance of our platform within the broader gene and cell therapy landscape.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Salva concluded&#58; &#8220;We are also excited to report the recent issuance of a new U.S. patent providing broad protection for our lead product, ATR-12, which we are advancing in a Phase 1b clinical trial for Netherton syndrome. With a strengthened balance sheet, expanding clinical execution, and multiple near-term catalysts, we believe Azitra is well positioned to drive continued progress across both our therapeutic pipeline and emerging cosmeceutical platform.&#8221;</font></div><div><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:107%;text-decoration:underline">Pipeline Achievements and Upcoming Milestones</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:107%">ATR-COSF - New Consumer Initiative to Improve the Appearance of Fine Lines and Wrinkles</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Results from synthesized filaggrin ingredients, repeat application study on explanted cosmetic surgery skin, expected mid-2026.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Human cosmetic application study planned for Q3 2026.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:107%">ATR-12 - Advancing Phase 1b Clinical Trial in Netherton Syndrome</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">In June 2025, Azitra reported promising safety data with 50% of patients enrolled. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">ATR12-351, a live biotherapeutic product candidate has been generally safe and well-tolerated with occasional, transient, mild to moderate symptoms at application site to date.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Topline data from the Phase 1b trial is anticipated H2 2026.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:107%">ATR-04 &#8211; Addressing an Unmet Need for Cancer Patients in a Multi-billion Dollar Market Opportunity</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Dosed first patient in Phase 1&#47;2 Trial for ATR-04 program targeting oncology patients with EGFRi-associated rash in Q3 2025.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Topline data from first cohort of Phase 1&#47;2 trial expected in H2-2026.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:107%">ATR-01 &#8211; Targeting Ichthyosis Vulgaris Which Impacts 1.3 million in the United States</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Announced positive preclinical data for ATR-01 program in Q3 2025, demonstrating delivery of active, functional filaggrin through human stratum corneum and repair of damaged model skin.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">IND-enabling studies continue in 2026. </font></div><div><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Financial Results for the Quarter Ended March 31, 2026</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:13.8pt">Research and Development (R&#38;D) expenses&#58;  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">R&#38;D expenses for the quarter ended March 31, 2026, were $1.6 million compared to $1.3 million for the comparable period in 2025.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:13.8pt">General and Administrative (G&#38;A) expenses&#58;  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">G&#38;A expenses for the quarter ended March 31, 2026, were $2.4 million compared to $1.9 million for the comparable period in 2025.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:13.8pt">Net Loss </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">was $3.9 million for the quarter ended March 31, 2026, compared to $3.1 million for the comparable period in 2025.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:13.8pt">Cash and cash equivalents&#58;  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> As of March 31, 2026, Azitra had cash and cash equivalents of $10.1 million.</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">About Azitra, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Azitra, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology. The Company's lead program, ATR-12, uses an engineered strain of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">S. epidermidis </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">designed to treat Netherton syndrome, a rare, chronic skin disease with no approved treatment options. Netherton syndrome may be fatal in infancy with those living beyond a year having profound lifelong challenges. The ATR-12 program includes a Phase 1b clinical trial in adult Netherton syndrome patients. ATR-04, Azitra's additional advanced program, utilizes another engineered strain of S. epidermidis for the treatment of EGFR inhibitor (&#34;EGFRi&#34;) associated rash. Azitra has received Fast Track designation from the FDA for EGFRi associated rash, which impacts approximately 150,000 people in the U.S. Azitra has an open IND for its ATR-04 program in patients with EGFRi associated rash. The ATR-12 and ATR-04 programs were developed from Azitra's proprietary platform of engineered proteins and topical live biotherapeutic products that includes a microbial library comprised of approximately 1,500 bacterial strains. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts, and helps screen the library of strains for drug like molecules. Azitra is also developing its proprietary filaggrin protein and peptide technologies for the consumer, cosmeceutical market. The new initiative is the first amongst </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">others, which aims to leverage Azitra's microbial genetic engineering platform to manufacture innovative proteins and peptides for the cosmetic and research markets.  For more information, please visit </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">https&#58;&#47;&#47;azitrainc.com</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:9pt;margin-top:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Forward-Looking Statements</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may be identified by words such as &#8220;aims,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;forecasts,&#8221; &#8220;goal,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;seeks,&#8221; &#8220;will,&#8221; and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements include, without limitation, statements regarding the expected timing of (i) our provision of initial safety data and topline results for the Phase 1b trial for our ATR-12, (ii) the abstract detailing the Phase 1&#47;2 clinical trial for our ATR-04 program, (iii) our provision of initial safety data and topline results for the Phase 1&#47;2 clinical trial for our ATR-04 program, and (iv) statements about our clinical and preclinical programs, and corporate and clinical&#47;preclinical strategies, including our cosmeceutical strategy.</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Any forward-looking statements in this press release are based on current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to&#58; the timing of clinical trials and their results&#59; we may experience delays in the provision of initial safety data and topline results for ATR-12 and ATR-04 and, if we do, such data and results may not be favorably received&#59; the safety and efficacy of our product candidates&#59; possible delays in regulatory approval or changes in regulatory framework that are out of our control&#59; our estimation of addressable markets of our product candidates may be inaccurate&#59; we may fail to timely raise additional required funding&#59; more efficient competitors or more effective competing treatment may emerge&#59; we may be involved in disputes surrounding the use of our intellectual property crucial to our success&#59; we may not be able to attract and retain key employees and qualified personnel&#59; earlier study results may not be predictive of later stage study outcomes&#59; and we are dependent on third-parties for some or all aspects of our product manufacturing, research and preclinical and clinical testing. Additional risks concerning Azitra&#8217;s programs and operations are described or incorporated by reference in our annual report on Form 10-K filed with the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) on February 27, 2026 and our quarterly report on Form 10-Q filed on May 13, 2026 with the SEC. Azitra explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Contact</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Norman Staskey</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Chief Financial Officer</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">staskey&#64;azitrainc.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Investor Relations</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Tiberend Strategic Advisors, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Jon Nugent</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">205-566-3026</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">jnugent&#64;tiberend.com</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Media Relations </font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Tiberend Strategic Advisors, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Casey McDonald </font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">646-577-8520 </font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">cmcdonald&#64;tiberend.com</font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ia1abca59ecaf42d6b4ce8a96c5d9acf8_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Condensed Statement of Operations</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">(Unaudited)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.037%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.003%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top">Three Months Ended March 31,</td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">2026</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">2025</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">General and administrative</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,373,359&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,850,138&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Research and development</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,560,565&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,250,100&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total operating expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,933,924&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">3,100,238&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Loss from operations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,933,924)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(3,100,238)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other income (expense)&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Interest income</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">14,719&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">37,164&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Interest expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(3,411)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(1,293)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Change in fair value of warrants</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">143&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other income</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(4,624)</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(4,121)</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total other income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">6,684&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">31,893&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Loss before income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(3,927,240)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(3,068,345)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Income tax expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(3,927,240)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(3,068,345)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Net loss per Share, basic and diluted</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.25)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.55)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Weighted average common stock outstanding, basic and diluted</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,517,992</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,977,670</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ia1abca59ecaf42d6b4ce8a96c5d9acf8_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Condensed Balance Sheets</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Unaudited</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.435%"><tr><td style="width:1.0%"></td><td style="width:40.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.946%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.235%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.347%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">March  31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">December 31,</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">2026</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">2025</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Assets</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Current Assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">10,051,003&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2,068,083&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other receivables</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">154,492&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">141,295&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">554,646&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">809,949&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">10,760,141&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">3,019,327&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">530,438&#160;</font></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">548,591&#160;</font></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">836,225&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,457,468&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total assets</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">12,126,804&#160;</font></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5,025,386&#160;</font></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Liabilities and stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Accounts payable</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">932,217&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">399,356&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Current financing lease liability</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5,850&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">10,111&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Current operating lease liability</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">240,740&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">255,776&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Insurance premium financing liability</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">100,463&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">198,983&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">270,511&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">203,740&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total current liabilities</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,549,781&#160;</font></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,067,966&#160;</font></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Long-term financing lease liability</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Long-term operating lease liability</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">96,740&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">156,190&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Warrant liability</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total liabilities</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,646,521&#160;</font></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,224,156&#160;</font></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Common stock</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,619&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,074&#160;</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additional paid-in capital</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">82,927,100&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">72,321,352&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Accumulated deficit</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(72,448,436)</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(68,521,196)</font></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">10,480,283&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">3,801,230&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total liabilities and stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td><td colspan="2" style="background-color:#bfe4ff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">12,126,804&#160;</font></td><td style="background-color:#bfe4ff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td><td colspan="2" style="background-color:#bfe4ff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5,025,386&#160;</font></td><td style="background-color:#bfe4ff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>aztr-20260513.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d259a-22e3-7c8b-971e-5774f3923c7f,g:56b54348-e223-4b5f-97fa-e119bcd9767f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:aztr="http://www.azitrainc.com/20260513" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.azitrainc.com/20260513">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aztr-20260513_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aztr-20260513_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.azitrainc.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>aztr-20260513_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d259a-22e3-7c8b-971e-5774f3923c7f,g:56b54348-e223-4b5f-97fa-e119bcd9767f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_019d259a-22e3-7935-a894-af70c0f030a3_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_019d259a-22e3-7a2e-9529-3a8d357ebb23_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019d259a-22e3-7c6f-b7ee-17666583209e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019d259a-22e3-7552-929d-562d5d8af5a5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_019d259a-22e3-7706-bd44-842813f06be3_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_019d259a-22e3-7533-a350-c7da062a5773_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019d259a-22e3-7aff-83a0-bb484140105a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019d259a-22e3-7f18-8d49-8376aae97b95_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_019d259a-22e3-767d-b527-30f757d27ea1_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019d259a-22e3-7889-b698-18060a41cc01_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019d259a-22e3-7cc7-b36f-c5b71702f0cc_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019d259a-22e3-7498-98a1-21a9094bc2ce_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019d259a-22e3-7c69-a7a5-7225344199f2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019d259a-22e3-7196-8630-b1f05782512c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019d259a-22e3-7110-bb71-63b45f17b987_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019d259a-22e3-7899-bd83-24987ef68a29_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019d259a-22e3-7b26-a1f1-525c89daa990_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019d259a-22e3-726a-9cd6-374281a68a18_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019d259a-22e3-72f1-b4dc-af2db84fe6b7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019d259a-22e3-7ecb-b385-f8da147e1286_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019d259a-22e3-715d-b396-0a00eb7d4eb2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019d259a-22e3-7656-8405-fe8e78a8f7b4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019d259a-22e3-7b13-8db3-4fc38b17e535_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>aztr-20260513_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d259a-22e3-7c8b-971e-5774f3923c7f,g:56b54348-e223-4b5f-97fa-e119bcd9767f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.azitrainc.com/role/Cover" xlink:type="simple" xlink:href="aztr-20260513.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.azitrainc.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019d259a-22e3-7349-88a4-05c8c35947fb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_DocumentType_019d259a-22e3-7349-88a4-05c8c35947fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019d259a-22e3-7bb3-b01e-52f7207ecc9f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_DocumentPeriodEndDate_019d259a-22e3-7bb3-b01e-52f7207ecc9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019d259a-22e3-778b-ab85-df66297341ff" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_EntityRegistrantName_019d259a-22e3-778b-ab85-df66297341ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019d259a-22e3-7c13-b0aa-700a449ccdd0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019d259a-22e3-7c13-b0aa-700a449ccdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019d259a-22e3-732a-bccb-bce484b489c8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_EntityFileNumber_019d259a-22e3-732a-bccb-bce484b489c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019d259a-22e3-71b5-86f0-004b6afd7d08" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_EntityTaxIdentificationNumber_019d259a-22e3-71b5-86f0-004b6afd7d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019d259a-22e3-7cee-85d3-ac0d08a9f80b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_EntityAddressAddressLine1_019d259a-22e3-7cee-85d3-ac0d08a9f80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019d259a-22e3-7a26-a9c2-8c53f3490fd7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_EntityAddressCityOrTown_019d259a-22e3-7a26-a9c2-8c53f3490fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019d259a-22e3-797f-abef-463b3be06872" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_EntityAddressStateOrProvince_019d259a-22e3-797f-abef-463b3be06872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019d259a-22e3-733d-af01-c500bc322691" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_EntityAddressPostalZipCode_019d259a-22e3-733d-af01-c500bc322691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019d259a-22e3-7391-ad38-9bd05a4c29aa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_CityAreaCode_019d259a-22e3-7391-ad38-9bd05a4c29aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019d259a-22e3-7b13-a31a-714ec881746e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_LocalPhoneNumber_019d259a-22e3-7b13-a31a-714ec881746e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_019d259a-22e3-7247-ae76-f9b6eb70766a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_WrittenCommunications_019d259a-22e3-7247-ae76-f9b6eb70766a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_019d259a-22e3-70ce-8597-b2290f3e89e1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_SolicitingMaterial_019d259a-22e3-70ce-8597-b2290f3e89e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_019d259a-22e3-7d22-86a1-e29368f40aec" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_PreCommencementTenderOffer_019d259a-22e3-7d22-86a1-e29368f40aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_019d259a-22e3-70f5-b5ff-2e57c0a74cc0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_019d259a-22e3-70f5-b5ff-2e57c0a74cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019d259a-22e3-7782-b032-1929db305bc3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_Security12bTitle_019d259a-22e3-7782-b032-1929db305bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019d259a-22e3-7145-9dd3-7e3a02affd03" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_TradingSymbol_019d259a-22e3-7145-9dd3-7e3a02affd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019d259a-22e3-795c-8389-b99eb4bb0928" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_SecurityExchangeName_019d259a-22e3-795c-8389-b99eb4bb0928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019d259a-22e3-7e09-b924-99d3b3c2257e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_EntityEmergingGrowthCompany_019d259a-22e3-7e09-b924-99d3b3c2257e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_019d259a-22e3-7b1c-8b4d-c2ebc660f3a8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_EntityExTransitionPeriod_019d259a-22e3-7b1c-8b4d-c2ebc660f3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019d259a-22e3-71c2-9d04-fdbbff338673" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_AmendmentFlag_019d259a-22e3-71c2-9d04-fdbbff338673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019d259a-22e3-7361-9391-f7e33e1ccad9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d259a-22e3-7486-925d-553140937032" xlink:to="loc_dei_EntityCentralIndexKey_019d259a-22e3-7361-9391-f7e33e1ccad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0a.jpg
MB5!.1PT*&@H    -24A$4@   Z,   '." 8   !MD]^Q   U/TE$051XVNW=
M>;@E9UTG\&_5N;UW5B A[ *R"TIDD<4DW0TZCLNXH> "J @DW9VPN;"%*"B;
MD*2[ X*B(PHR.",*,PAT=PC(*B *ADW9MR20A?26]#UUYH_JD(5[[M)W>>N<
M\_D\SWV2I]_35=\Z?>^M\ZMZZ_<F
M
M
M
M
M
M
M
M
M
M                             ".N*AT  /BNO4EN4VC?_Y#DN:7?   F
MQU3I  # =]TKR2F%]OW1T@</P&2I2P<   !@\BA& 0  6'&*40   %:<8A0
M ( 5IQ@%  !@Q2E& 0  6'&*40   %:<=48!@!(>F^2VA?;][21_5?H-
MZ(JO)QD4^OK+%3[6#Q8\UD^N\+$", /3= $  %AQBE$   !6G&(4  " %:<8
M!0  8,4I1@$  %AQBE$   !6G&(4  " %:<8!0  8,4I1@$  %AQBE$   !6
MG&(4  " %:<8!0  8,4I1@$  %AQBE$   !6G&(4  " %3>UW#O8MV/+WU95
M]7-U7:TJ?;!=UC1-/U7UQ0UGO>ONI;, 4,SM2@< @)6RK'=&#^Y\U)=ZO?J7
M%*)SJ^NZ5U?5W0Y>].A!Z2P   #+;=F*T>9E]]^0NKI3Z0,<10<NV'Q^Z0P
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MT*XMYY7."   L%26I!B=[DU]?.A@?W#)]YWWI4.E#W045$U^8_A@_;S2^0
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M_)G2&9,<+KS_+A3DP_QYZ0!+Z)IT_X[C79-\JW0(N(FOEP[ O)5>A_@MI=^
M61R3Y#&E0\#14(QVR/JS]I[9-(.AZX[N>^7I7>^,.7'JNCI]V-CT8/IAI?,=
M47HJ6E<[^]TWR6^4#K%$IM/]I2H>GN2+I4/0*8/%;V+13DGRNM(AF)?2,S].
M7?PFED65]F(DC"3%:,=4:?YTV%B]:NH?2^?C1OLOW'3IL+&F::X]=OLEGRZ=
M\8@=I0.DO2/6);=*\LG2(69P-.O#?3;=OR/Z_"3O+QV"SOE*Z0!'/#%MH?.
MTD'HO'>5#G +5=K.Y%U;6W1CZ0",#L5HQZS?NN>IP\:JNEY][8[-X[86XLBJ
MIZ;N/6QL_:'#72J^NO"![[.E ]S$R>GN5-&%_D[^VR3?7SKT'-Z:Y ]+AZ"3
MOE@ZP$VL3_+QM,\S?SC)TS/_9P3OG>2Y2?:F_7T["MVL.3I;TJW?N=>DF\O.
MW+9T $:'8K2#^OWIH=W0IGJ]ORF=C^3@18]Z]["QIAD,JF=>TM5BIY1>NE$
M/BK=[C8[M<#7_WSIP//P4VFG8T[J%\-]J72 &51)'I3D3](6EO/Y-[XT[067
M,]+])C>CK@L_4Y]--SX_#]+=);).*1V T=&%'R9N8>.VO7\PV_C!B[9X=K2@
MP;EW7IM4IPT;OV[ZP%U*9^RH6R6YLN#^WY?DG:7?A#GXG<PD^4+I (R<EY8.
M<$0_[3FMA.WI1E$^&\4H\^:#3U<-FE<.'ZS_:?X;8JD=N,W=_^_0P:9_Y8GG
MO._+I3/.X$\7OXDE<4+::7 _LH+[?'3:#PY=:2@UFV-+!X 5]/;%;X()TZ5F
M4]]*\L(5W-\Q2;Z=Y(+2!SX/76^H1X<H1CMJW5F[GS[;^+7GG[ZY=,9)-$BJ
MNNYM&C9>'3KP\-(9A^C*U>2DG0;W_B2'DIRXC/LY/<GU2=Z1T?E==U+I +""
MNGYWA^[I4O^!)'E.VHN=3U[&?:Q.VZ3H.UG><R84,2H?T";2=+\_O+/NU-0[
M2N>;1 =V;1G>(;=IKES[S ]TI8/N+7V^=( 9K$E[E7>0Y -)'IEDPR*V=[LD
MOYZVH<,@R<5)5I4^R 52C +,KFL%:9WDU6G/.U>G7>_SY$5L[[BT%U,_?F2;
MUV5QYT;HM(4VRV %';-MSU,.7O3H&:^VU77=.W#A&;^^?OO%?U4ZYR2IJ_H>
MP\;ZUU]WO]+YYO!_DOQ<Z1!#/#3)>V[Q9Y>G;7!R39*KCOQW*LG:M%>';YOD
M^]+=!@Y'PW,V +-[7)*/E XQQ'%)WG2+/SN8Y#-I"]6KTY[+^FG/9<>D/9?=
M,3K0,J$4HQW7[T\_M]>;FOF9A+KWNB2*T15R<-?F#\XVOO'I[_U&Z8QS^+5T
MMQB=R4F9O#N%9Z0;Z\+"2GEYDF>6#L%(^6C:.X9=6UMSF'5)?K!T".@JTW0[
M;N.VO2\:-E;5=>_0SLT_4SKC)!B<>Y_5J7H/&3:^9E6QKGH+<2#)M:5#,*M'
ME0X *^PEI0,PDOZV= !@:2A&1T$S_<?#A@9U[RVEXTV" [<Y97C7QZ:YJG[2
M.TLN6;(0=R\=@%EM+!T 5E@7UA]F]#RN= !@:2A&1\"ZK7N?/=OXP0L?N6F^
MVV+A!N?>9_5L'73W'3H\"DN&W.#RM!UF ;IB9^D C*3?*!T 6#S%Z(@83$^_
M:NC@U+H]I?.-LP,GG?)O0P<'_2MN\\Q+NMI!=YC;E X <!/;2@=@)/U%DNG2
M(8#%48R.B/7;]YXYV_B^G9N>4#KCN*JKWKV&C373TP\LG>\H?"?)'Y4. 7 3
M'RH=@)'DT9/NNF/I (P&Q>@(Z3?3SQDV5E6]UY;.-XX.[-S\\=G&-YQ]R5=+
M9SQ*STG;8IZ9?:)T )@P#RT=@)'TI21O*!VBPUY:<-\/6?PFF 2*T1&R<>O>
MH7>SZJJ:NF[7Z;]4.N,XN?C<3%5U[P'#QM=>]M4UI3,NT@FE W10DW:Y@,\4
MS# JRQ7 4O/AE:/Q*VF[Q7.C09(')?GCQ6YH$1Y3^DU@-"A&1\R@:5XP;*RI
M5FMUOH0>?-*6=PT;&S2#:ZKS+AV'1D#'E@[0(?N3]([\_T<+YGA\Z3<""OEP
MDG\J'8*1M"')H=(A.N1N23Z2LC.@?J#TF\!H4(R.F/5;=Y\WV_B^"T[[\=(9
MQ\'7SCUU?5W5IP\;KZ>O>U#IC$ODVI@>ER2?S<V752GY@?BW"[\74-)_2_+-
MTB$82<>EO2,XZ=8G^4+I$/$\+_.D&!U!_7Y_:!O\WJHU;U_(MIC9\;<^[B/#
MQ@:#_A5KSWG/YTIG7$(?2G*73.Y)_&5)[GF+/_MXP3SW*+AOZ()38@DJ%N[Z
MM)]K^Z6#%/+5M(]Y'"P=Y(BIT@$8#8K1$;1QVYY9V^ ?O%!GW<6J>U/W'CIX
MN/KATOF6P9>2C/HSL MU?9+;)_F=TD%NX5:E T 'K$GR;XO>"I-H*I-W=WU[
MNMF]]OZE ]!]BM$1U>]//W?86-/367<Q]N_8,G3=T*9IKE]_SNXOE\ZX3 XG
M69WDZZ6#K(#7I_VP.]NQ7E<PWYT*[ANZX@>3_&;I$(RD4Y+\6>D0*^"*).N2
M[)CE-2\LF._7"NZ;$:$8'5$;M^U]T;"QNJJF#ERT61.4HU3WZGL.&]NP=?>X
MWST\G/9NX;@N0G]=VFE,OSZ/UY:<\OZ'!?<-7?*ZM#^STZ6#,'*>E/9S[C@^
M@C)(<GR2DS)WXZ:2YY-G%MPW(T(Q.L+Z_>;WAHU5Z?UEZ7RCZ."N3>\=-M8T
MS;6E\ZV@G6D[R_Y[Z2!+Y)MI[S:N7<#?*;E4TGR*99@DJ]).8?]*Z2",E$':
MS[JO*1UDB31ISP]UDFOF^7=*/W^]KO#^Z3C%Z C;N&WW2V8;WW_!YI\IG7&4
M#':>MC'5U".&C5]_^/"D/?O0)'E DN]+=QHB+-2'DMPA[92MA7Z(+7T"UXD0
M;N[*M!>5UB1Y1>DPC)0GI_W,^][%;JB0:Y*<EO8B\>N/XN]_IV#VMQ7<-R-
M,3KBFJ;_\F%C]:K>6TKG&R4'T_O L+%!T[_BA*==\L72&0OY8MI6\7,]8]DE
MF]).[7MHDJ\M8CLEB_#/%MPW=-GU29Z1]F=\39(7E [$2!@D^=&T!=U%I</,
MT\O3S@HX/LE[%K&=,PL>PZ:"^V8$5*4#L'C[=SZJJ>MJQG_+_G3_\1NW[_FK
MTAE'P<&+'CWTN9)!<_@NZ[=>_*72&3OD%](NB7*7TD'2MO'_8)*G)_EPZ3!
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MU^EH"@  RT Q.D:F^\T+AXU5J^HWE<[711LVKAO:G6XP&%Q6/_V]WRB=$0
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M=-E@>O"!C=MWO[9T#@
M
M
M
M
M
M
M
M
M
M
M
M
M                                      "@R_X_WS+5F/ZC+U8
(245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 27, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 13,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">AZITRA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4478536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">21 Business Park Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Branford<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">646-6446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AZTR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001701478<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="aztr-20260513.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.azitrainc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="aztr-20260513.htm">aztr-20260513.htm</File>
    <File>aztr-20260513.xsd</File>
    <File>aztr-20260513_lab.xml</File>
    <File>aztr-20260513_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "aztr-20260513.htm": {
   "nsprefix": "aztr",
   "nsuri": "http://www.azitrainc.com/20260513",
   "dts": {
    "inline": {
     "local": [
      "aztr-20260513.htm"
     ]
    },
    "schema": {
     "local": [
      "aztr-20260513.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "aztr-20260513_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aztr-20260513_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://www.azitrainc.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aztr-20260513.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aztr-20260513.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.azitrainc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001701478-26-000029-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001701478-26-000029-xbrl.zip
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M?,.S\UU3HWN0B@D^]R(_]!!P*DK&UW/OYOH*GWKGB\GD[ /&MY]62W0I:-<
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M"L;KM?]_LH+.L-_KQ>0/4$L#!!0    ( #FAK%PN?</-B@D  /17   5
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M2SL>I2\VGKTKE88^O87W02Q)O'S+VD[,_=OW[0G\&,6N\^H_4$L! A0#%
M  @ .:&L7%,@IM#R#P  +G$  !$              ( !     &%Z='(M,C R
M-C U,3,N:'1M4$L! A0#%     @ .:&L7%'V FIA @  _ 8  !$
M     ( !(1   &%Z='(M,C R-C U,3,N>'-D4$L! A0#%     @ .:&L7"Y]
MP\V*"0  ]%<  !4              ( !L1(  &%Z='(M,C R-C U,3-?;&%B
M+GAM;%!+ 0(4 Q0    ( #FAK%S8<($5# 8  /<R   5              "
M 6X<  !A>G1R+3(P,C8P-3$S7W!R92YX;6Q02P$"% ,4    "  YH:Q<RB![
M^A@>  !S<0$ '@              @ &M(@  87IT<G!R97-S<F5L96%S93,S
B,3(P,C8M97@N:'1M4$L%!@     %  4 4 $   %!      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>aztr-20260513_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aztr-20260513.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701478</identifier>
        </entity>
        <period>
            <startDate>2026-02-27</startDate>
            <endDate>2026-02-27</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-23">0001701478</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2026-05-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">AZITRA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-41705</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">46-4478536</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">21 Business Park Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Branford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">06405</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">(203)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">646-6446</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">AZTR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-21">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
